Trial NCT02630186

View at ClinicalTrials.gov 
Org. Study IDs: CO-1686-032

Last trial update was posted on 2019-07-05

MeSH Interventions

Atezolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

The study terminated before Phase 1 was completed. This study was reprioritized within the rociletinib development program.

Limitations And Caveats

This study was terminated early which lead to small number of subjects analyzed. The study did not reach the target number of participants needed to achieve target power and statistically reliable results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID